Keyphrases
Therapeutic Target
100%
Adult-onset
100%
Spinocerebellar Ataxia
100%
Neurodevelopmental Deficits
100%
Cerebellum
75%
Inhibitory Neurons
50%
Mutant Protein
50%
Purkinje Cell
50%
Stem Cells
50%
Early Developmental Stages
25%
Putative Drug Targets
25%
GABAergic Inhibition
25%
Biological Changes
25%
Polyglutamine Expansion
25%
Late-onset
25%
Drug Model
25%
Stem number
25%
Developmental Changes
25%
Molecular Changes
25%
Glial Cells
25%
Changes in Function
25%
Cell Support
25%
Ataxin-1
25%
Mouse Model
25%
Cellular Level
25%
Neurodegenerative Diseases
25%
Movement Execution
25%
Toxic Effects
25%
Neuroscience
Spinocerebellar Ataxia
100%
Cerebellum
75%
Purkinje Cell
50%
Mutant Protein
50%
Stem Cell
50%
Neurodegenerative Disorder
25%
GABAergic Inhibition
25%
Polyglutamine
25%
Ataxin 1
25%
Microglia
25%